Clinical research

Medical Writing and Publication Support

Clear, accurate and compliant scientific documentation for every stage of clinical development, registration and publication, prepared by medical writers who master both the science and the expectations of each audience.

The quality of your documentation shapes how regulators, ethics committees, investigators and the scientific community perceive your product. A well-constructed protocol progresses through approval efficiently, a rigorous clinical study report anticipates the reviewer’s questions, and a compelling manuscript gives your results the visibility they deserve.

Our medical writers bring backgrounds in medicine, pharmacy and the life sciences, and collaborate daily with our clinical operations, biostatistics, pharmacovigilance and regulatory teams. They understand the studies behind every document and the expectations of every reader.

Each document undergoes scientific review and comprehensive quality control against its source data before delivery, so you receive a document ready for approval rather than a draft requiring revision.

Doctor writing on a medical document
Clinical and regulatory writing

Documentation across the full product lifecycle

From the first protocol to the final publication, our medical writers prepare the documents on which regulators, ethics committees, investigators and the scientific community depend.

  • Clinical trial protocols and amendments

    Comprehensive protocols following ICH M11 and SPIRIT, and well-justified amendments when a study must evolve.

  • Informed consent documents

    Participant information and consent forms in Arabic and English, written in clear and respectful language.

  • Investigator’s brochures

    Initial brochures and annual updates consolidating the clinical and non-clinical evidence on the investigational product.

  • Clinical study reports

    Full and abbreviated clinical study reports in line with ICH E3, including synopses and appendices.

  • CTD clinical summaries and overviews

    Module 2.5 clinical overviews and Module 2.7 clinical summaries for registration dossiers.

  • Clinical evaluation reports

    Clinical evaluation reports for medical devices, founded on a systematic appraisal of the clinical evidence.

  • Safety narratives

    Precise, well-structured narratives for serious adverse events and other events of special interest.

  • Periodic safety reports

    Development safety update reports (DSURs) and periodic benefit-risk evaluation reports (PBRERs), prepared jointly with our pharmacovigilance team.

  • Risk management plans

    Risk management plans and their updates, characterising the safety profile and the measures to minimise risk.

  • Responses to regulatory questions

    Well-reasoned, fully referenced responses to enquiries from the Egyptian Drug Authority and other regulators.

Our methodology

A rigorous path from brief to final document

  1. 01

    Brief and planning

    The purpose, audience, governing guideline, timeline and review cycles are agreed for each document at the outset.

  2. 02

    Source evaluation

    Our writers examine the protocol, data, statistical outputs and literature, and resolve open questions before drafting begins.

  3. 03

    Drafting

    The first draft follows the applicable guideline and your template, built around key messages agreed with you in advance.

  4. 04

    Expert review

    Our medical, statistical and regulatory specialists review the draft for scientific accuracy and soundness of interpretation.

  5. 05

    Quality control

    Every figure, table and reference is verified against its source, and the document is checked for consistency and style.

  6. 06

    Finalisation

    Reviewer comments are consolidated and resolved with you, and a final, version-controlled document is delivered.

Publication and scientific communication

Bringing your findings to the scientific community

Robust research merits a wide and informed readership. We support the publication of your results and their clear communication to healthcare professionals and patients.

  • 01

    Journal manuscripts

    Original research articles following CONSORT, STROBE and ICMJE recommendations, from first draft through to acceptance.

  • 02

    Journal selection and submission

    Guidance on target journals, preparation of the submission package and considered responses to peer reviewers.

  • 03

    Abstracts, posters and presentations

    Congress abstracts, scientific posters and presentations for national and international meetings.

  • 04

    Systematic and literature reviews

    Structured appraisals of the published evidence to inform study design, regulatory submissions and publications.

  • 05

    Plain-language summaries

    Summaries of study results for participants and the public, in Arabic and English.

  • 06

    Medical education materials

    Scientifically accurate materials for healthcare professionals, reviewed for balance and compliance.

Standards

Aligned with the guidelines that govern each document

  • 01

    ICH E3, M11 and M4

    Structure and content of clinical study reports, clinical protocols and the Common Technical Document.

  • 02

    ICH E2F and E2C (R2)

    Development safety update reports and periodic benefit-risk evaluation reports.

  • 03

    CONSORT, STROBE and ICMJE

    Reporting standards for trials and observational studies, and recommendations for journal publication.

  • 04

    Good Publication Practice

    Ethical and transparent publication of company-sponsored research.

Let’s discuss your next project

Share your scope, timeline and budget. We will come back with a clear plan, defined milestones and a named project lead who is accountable for delivering on time, within budget and to the quality you expect.

  • Defined scope
  • Agreed milestones
  • On time
  • Within budget
Start your project